- Takeda Pharmaceutical has fully launched Orzeyful, a narcolepsy treatment that targets the root cause rather than addressing only the symptoms.
- The launch follows roughly 15 years of development at Takeda, which began work on the drug at its Shonan Health Innovation Park site in Fujisawa, Japan.
- The source describes Orzeyful as a drug once thought impossible to develop. The source body does not give a launch date, sales guidance, or pricing.
Quotes
“Japan's Takeda Pharmaceutical has fully launched Orzeyful, a narcolepsy treatment that targets the root cause rather than addressing only the symptoms.”